Time to eradicate HTLV-1: an open letter to WHO

Lancet. 2018 May 12;391(10133):1893-1894. doi: 10.1016/S0140-6736(18)30974-7. Epub 2018 May 10.

Authors

Fabiola Martin¹, Yutaka Tagaya², Robert Gallo²

Affiliations

¹ Faculty of Medicine, University of Queensland, Brisbane, QLD 4072, Australia; Hull and York Medical School, University of York, York, UK; HTLV-1 Task Force, Global Virus Network, Baltimore, MD, USA. Electronic address: fabiola.martin@uq.edu.au.
² HTLV-1 Task Force, Global Virus Network, Baltimore, MD, USA; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, USA.

PMID: 29781438
DOI: 10.1016/S0140-6736(18)30974-7

No abstract available

Publication types

Letter

MeSH terms

Disease Eradication / organization & administration*
HTLV-I Infections / epidemiology
HTLV-I Infections / prevention & control*
HTLV-I Infections / transmission
Human T-lymphotropic virus 1*
Humans
World Health Organization*